overone
Greenlighter
Reversing overdose w/Suboxone is possible.
Personally, I have never eperienced first hand an attempt to reverse an opiate overdose with the use of suboxone, but I am a Bio major with minor in Chem. The idea to me is sound. In my opinion what would occur is that with a dose of suboxone (naloxone), it would react on the u-opioid receptors knocking off the full agonist opiate. The idea that mixing the two opiates, i.e. heroin and beprenorphine would only exacerbate the overdose situation, doesn't hold water. Being that opiates have smaller binding affinities than buprenorphine does.
Here is the conclusion of a case study of this exact subject performed jointly at U. of M. and at John Hopkins:
CASE REPORT
A case of heroin overdose reversed by sublingually administered buprenorphine/naloxone (Suboxone®)
Christopher Welsh, Susan G. Sherman & Karin E. Tobin. Department of Psychiatry, Division of Alcohol and Drug Abuse, University of Maryland School of Medicine, Baltimore, MD, USA, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA and Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Correspondence to Christopher Welsh, Department of Psychiatry, Division of Alcohol and Drug Abuse, University of Maryland School of Medicine, 22 S. Greene Street, Box 349,
P-1-H-10, Baltimore, MD 21201, USA. E-mail: [email protected]
Copyright Journal compilation © 2008 Society for the Study of Addiction
ABSTRACT
Background
Opioid overdose is a major source of morbidity and mortality in injection drug users in the United States and many other countries.
Case description
A case is described in which buprenorphine/naloxone (Suboxone®) was administered sublingually to reverse a heroin overdose.
Conclusions
Sublingually administered buprenorphine/naloxone might be used as a means to reverse opioid overdose.
--------------------------------------------------------------------------------
Submitted 17 January 2008; initial review completed 3 March 2008; final version accepted 19 March 2008
Personally, I have never eperienced first hand an attempt to reverse an opiate overdose with the use of suboxone, but I am a Bio major with minor in Chem. The idea to me is sound. In my opinion what would occur is that with a dose of suboxone (naloxone), it would react on the u-opioid receptors knocking off the full agonist opiate. The idea that mixing the two opiates, i.e. heroin and beprenorphine would only exacerbate the overdose situation, doesn't hold water. Being that opiates have smaller binding affinities than buprenorphine does.
Here is the conclusion of a case study of this exact subject performed jointly at U. of M. and at John Hopkins:
CASE REPORT
A case of heroin overdose reversed by sublingually administered buprenorphine/naloxone (Suboxone®)
Christopher Welsh, Susan G. Sherman & Karin E. Tobin. Department of Psychiatry, Division of Alcohol and Drug Abuse, University of Maryland School of Medicine, Baltimore, MD, USA, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA and Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Correspondence to Christopher Welsh, Department of Psychiatry, Division of Alcohol and Drug Abuse, University of Maryland School of Medicine, 22 S. Greene Street, Box 349,
P-1-H-10, Baltimore, MD 21201, USA. E-mail: [email protected]
Copyright Journal compilation © 2008 Society for the Study of Addiction
ABSTRACT
Background
Opioid overdose is a major source of morbidity and mortality in injection drug users in the United States and many other countries.
Case description
A case is described in which buprenorphine/naloxone (Suboxone®) was administered sublingually to reverse a heroin overdose.
Conclusions
Sublingually administered buprenorphine/naloxone might be used as a means to reverse opioid overdose.
--------------------------------------------------------------------------------
Submitted 17 January 2008; initial review completed 3 March 2008; final version accepted 19 March 2008